Financial Summary (All financials)
In millions of CNY, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 81.6 | 1,055.7 | 1,241.5 | 1,447.9 |
Revenue growth | -92.3% | -15.0% | -14.3% | |
Cost of goods sold | 69.4 | 483.7 | 607.1 | 755.4 |
Gross profit | 12.2 | 572.0 | 634.4 | 692.5 |
Gross margin | 14.9% | 54.2% | 51.1% | 47.8% |
Sales and marketing | | 250.9 | 310.4 | |
Research and development | | | | 32.3 |
General and administrative | 5.0 | 327.9 | 332.1 | 120.1 |
EBITA | 9.1 | -6.8 | -8.2 | -212.9 |
EBITA margin | 11.2% | -0.6% | -0.7% | -14.7% |
Amortization of intangibles | | | | 5.8 |
EBIT | 9.1 | -6.8 | -8.2 | -218.7 |
EBIT margin | 11.2% | -0.6% | -0.7% | -15.1% |
Pre-tax income | 6.7 | -12.1 | -11.8 | -215.5 |
Income taxes | -79.4 | -374.2 | -401.0 | 9.6 |
Tax rate | | 3092.0% | 3400.5% | |
Earnings from continuing ops | -26.4 | -758.5 | -812.0 | -219.4 |
Earnings from discontinued ops | 79.4 | 374.2 | 401.0 | |
Net income | 53.0 | -384.3 | -411.0 | -219.4 |
Net margin | 65.0% | -36.4% | -33.1% | -15.2% |
|
Diluted EPS | ($1.93) | ($1,668.87) | ($11,098.94) | ($136.02) |
Shares outstanding (diluted) | 13.7 | 0.5 | 0.1 | 1.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|